In univariate analysis (Fig. 8A), clinical characteristics (gender, age, T, N, M and tumor stage), APOA2, COX6A2, HIST1H1E, UBE2C, ERO1B and eight gene comprehensive risk scores were prognostic risk factors for patients with the EC (P < 0.05). Here, UBE2C is linked to neoplasm.